Profile
Clinton Musil worked as Vice President in Healthcare Investment Banking Group at Wells Fargo & Co. and Deutsche Bank AG from 2013 to 2017.
He also worked as Principal at Needham & Co. LLC, Vice President at Essex Woodlands Management, Inc., and Chief Business Officer at Personalis, Inc. In 2017-2018, he worked as Vice President of Corporate Development at ARMO BioSciences, Inc. In 2020-2021, he served as Chief Financial Officer at Catalyst Biosciences, Inc. Mr. Musil completed his undergraduate degree from the University of Arizona and earned an MBA from Harvard Business School.
Former positions of Clinton Musil
| Companies | Position | End |
|---|---|---|
| CATALYST BIOSCIENCES | Director of Finance/CFO | 28/10/2021 |
| ARMO BIOSCIENCES INC | Corporate Officer/Principal | 30/06/2018 |
| DEUTSCHE BANK AG | Corporate Officer/Principal | 28/02/2017 |
| WELLS FARGO & COMPANY | Corporate Officer/Principal | 30/06/2014 |
| PERSONALIS, INC. | Corporate Officer/Principal | - |
Training of Clinton Musil
| University of Arizona | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| PERSONALIS, INC. | Health Services |
| DEUTSCHE BANK AG | Finance |
| WELLS FARGO & COMPANY | Finance |
| Private companies | 4 |
|---|---|
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Finance |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Needham & Co. LLC (Needham) is a registered investment advisor and broker/dealer headquartered in New York City. The firm was founded in 1985 and is a wholly-owned indirect subsidiary of The Needham Group, Inc. Needham provides corporate and institutional clients with high quality research, corporate access, capital markets and trading execution services in both the public and private markets, with an emphasis on growth companies. | Finance |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology ARMO BioSciences, Inc. develops immunotherapy for the treatment of cancer, cardiovascular diseases, fibrosis, and inflammation. Its lead product candidate is AM0010 (pegilodecaki). The company was founded by Peter Van Vlasselaer, Martin Oft, and John B. Mumm on June 23, 2010 and is headquartered in Redwood, CA. | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Catalyst Biosciences, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Clinton Musil
